Cargando…
Biosimilars in rheumatology: understanding the rigor of their development
This article examines the current landscape of biosimilar development in rheumatology. As misperceptions about biosimilars exist regarding their comparability to the reference products for clinical use, we review the development paradigm with the goal of improving rheumatologists’ understanding of t...
Autores principales: | Goel, Niti, Chance, Kamali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410928/ https://www.ncbi.nlm.nih.gov/pubmed/27241704 http://dx.doi.org/10.1093/rheumatology/kew206 |
Ejemplares similares
-
The changing landscape of biosimilars in rheumatology
por: Dörner, Thomas, et al.
Publicado: (2016) -
Reproducibility and rigor in rheumatology research
por: Alnaimat, Fatima, et al.
Publicado: (2023) -
Corrigendum: Reproducibility and rigor in rheumatology research
por: Alnaimat, Fatima, et al.
Publicado: (2023) -
Biosimilars in rheumatology: A review of the evidence and their place in the treatment algorithm
por: Schulze-Koops, Hendrik, et al.
Publicado: (2017) -
Biosimilars in rheumatology: recommendations for regulation and use in Middle Eastern countries
por: El Zorkany, Bassel, et al.
Publicado: (2018)